[1] |
Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of turnouts: pathology and genetics of tumours of the urinary system and male genital organs[M]. IARC Press, Lyon, 2004: 37-38.
|
[2] |
周立军,谢华,陈方,等. 隐蔽切口法在机器人辅助腹腔镜下儿童肾肿瘤根治术标本取出中的应用体会[J]. 中华小儿外科杂志, 2020, 41(3): 201-204.
|
[3] |
Cost NG, Liss ZJ, Bean CM, et al. Prechemotherapy robotic-assisted laparoscopic radical nephrectomy for an adolescent with Wilms tumor[J]. J Pediatr Hematol Oncol, 2015, 37(2): e125-e127.
|
[4] |
Armah HB, Parwani AV, Surti U, et al. Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature[J]. Diagn Pathol, 2009, 4(1): 1-11.
|
[5] |
Calio A, Segala D, Munari E, et al. MiT family translocation renal cell carcinoma: from the early descriptions to the current knowledge[J]. Cancers (Basel), 2019, 11(8): 1110.
|
[6] |
Argani, P, Reuter VE, Zhang L, et al. TFEB-amplified renal cell carcinomas: an aggressive molecular subset demonstrating variable melanocytic marker expression and morphologic heterogeneity[J]. Am J Surg Pathol, 2016. 40(11): 1484-1495.
|
[7] |
Klatte T, Streubel B, Wrba F, et al. Renal cell carcinoma associated with transcription factor e3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis[J]. Am J Clin Pathol, 2012, 137(5): 761-768.
|
[8] |
Su HH, Sung MT, Chiang PH, et al. The preliminary experiences of translocation renal cell carcinoma and literature review[J]. Kaohsiung J Med Sci, 2014, 30(8): 402-408.
|
[9] |
Cheng X, Gan W, Zhang G, et al. Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies[J]. BMC Urol, 2016, 16(1): 40.
|
[10] |
瞿元元,张海梁,叶定伟, 等. Xp 11.2易位/TFE3基因融合相关性肾癌的临床病理特征分析[J]. 中华泌尿外科杂志, 2014, 35(9): 641-644.
|
[11] |
Kato H, Kanematsu M, Yokoi S, et al. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: radiological findings mimicking papillary subtype[J]. J Magn Reson Imaging, 2011, 33(1): 217-220.
|
[12] |
徐晓晨,甘卫东,李笑弓等. Xp11.2易位/TFE3基因融合相关性肾癌与肾透明细胞癌的螺旋CT诊断鉴别[J]. 现代泌尿外科杂志, 2012, 17(2): 122-124.
|
[13] |
Wang W, Ding JH, Li Y, et al. Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion[J]. Plos One, 2014, 9(6): e99990 1-9.
|
[14] |
van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, et al. Position paper: rationale for the treatment of Wilms tumor in the UMBRELLA SIOP-RTSG 2016 protocol[J]. Nat Rev Urol. 2017, 14(12): 743-752.
|
[15] |
Cost NG, Geller JI, DeFoor WR, et al. A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection[J]. J Pediatr Surg, 2012, 47(10): 1946-1950.
|
[16] |
Blanc T, Pio L, Clermidi P, et al. Robotic-assisted laparoscopic management of renal tumors in children: Preliminary results[J]. Pediatr Blood Cancer. 2019, 66(Suppl. 3): e27867.
|
[17] |
Sausville JE, Hernandez DJ, Argani P, et al. Pediatric renal cell carcinoma[J]. J Pediatr Urol, 2009, 5(4): 308-314.
|
[18] |
Burnand K, Roberts A, Bouty A, et al. Laparoscopic nephrectomy for Wilms' tumor: can we expand on the current SIOP criteria?[J]. J Pediatr Urol, 2018, 14(3): 253. e1-253.e8.
|
[19] |
Crispen PL, Breau RH, Allmer C, et al. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates[J]. Eur Urol, 2011, 59(1): 18-23.
|
[20] |
Thiery M. Hermann J. Pfannenstiel (1862-1909) and the Pfannenstiel incision[J]. Gynecol Surg, 2010, 7(1): 93-95.
|
[21] |
Strub T, Giuliano S, Ye T, et al. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma[J]. Oncogene, 2011, 30(20): 2319-2332.
|
[22] |
Ellis CL, Eble JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage[J]. Mod Pathol, 2014, 27(6): 875-886.
|
[23] |
Malouf GG, Camparo P, Oudard S, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network[J]. Ann Oncol, 2010, 21(9): 1834-1838.
|
[24] |
Ahluwalia P, Nair B, Kumar G. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a rare case report with review of the literature[J]. Case Rep Urol, 2013, 2013: 810590.
|
[25] |
Kuroda N, Mikami S, Pan CC, et al. Review of renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions with focus on pathobiological aspect[J]. Histol Histopathol, 2012, 27(2): 133-140.
|
[26] |
Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma[J]. Cancer, 2004, 101(7): 1575-1583.
|